Skip to Content

Tag: Kerecis


In brief: ADS taps Bill Mixon as CEO, Coloplast buys Kerecis

July 12, 2023HME News Staff

CARLSBAD, Calif. - Advanced Diabetes Supply has appointed Bill Mixon, who previously led National Seating & Mobility, as its CEO.  The announcement follows the transition of the company’s co-founders and co-CEOs, Mark Howard and Tim Cady, to strategic advisory roles as members of the board of directors.  “Bill has provided valuable insight and support to the ADS leadership team as a board member for the last two years,” said Jeffrey Abramoff, a partner at Court Square,...

Advanced Diabetes Supply (ADS), Bill Mixon, Coloplast, Kerecis

Read Full Articlered right arrow icon


Coloplast expands into biologics wound care segment 

July 10, 2023HME News Staff

MINNEAPOLIS – Coloplast has signed an agreement to buy Kerecis, a biotech company based in Iceland that is pioneering the use of fish skin in the regenerative medicine market, for up to $1.3 billion.  Coloplast will pay $1.2 billion upfront on a cash and debt-free basis and will pay up to a $100 million earnout dependent on financial performance in fiscal year 2023-24.  “The advanced wound care market holds significant untapped potential, and today Coloplast is only present...

Coloplast, Kerecis, Mergers & Acquisitions (M&A)

Read Full Articlered right arrow icon